0001209191-20-025998.txt : 20200428 0001209191-20-025998.hdr.sgml : 20200428 20200428174253 ACCESSION NUMBER: 0001209191-20-025998 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200428 FILED AS OF DATE: 20200428 DATE AS OF CHANGE: 20200428 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COLUMN GROUP II, LP CENTRAL INDEX KEY: 0001600420 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39269 FILM NUMBER: 20826367 BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 4158652050 MAIL ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Column Group II GP, LP CENTRAL INDEX KEY: 0001645333 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39269 FILM NUMBER: 20826368 BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-865-2050 MAIL ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOEDDEL DAVID V CENTRAL INDEX KEY: 0001182464 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39269 FILM NUMBER: 20826369 MAIL ADDRESS: STREET 1: C/O COLUMN GROUP LP STREET 2: 1700 OWENS STREET, SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oric Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001796280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 471787157 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 240 E. GRAND AVE. STREET 2: 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 388-5600 MAIL ADDRESS: STREET 1: 240 E. GRAND AVE. STREET 2: 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-28 0 0001796280 Oric Pharmaceuticals, Inc. ORIC 0001600420 COLUMN GROUP II, LP 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 0 0 1 0 0001645333 Column Group II GP, LP 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 0 0 1 1 General Partner 0001182464 GOEDDEL DAVID V 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 0 0 1 1 Managing Partner Common Stock 2020-04-28 4 C 0 3500000 A 3575000 D Common Stock 2020-04-28 4 C 0 625000 A 4200000 D Common Stock 2020-04-28 4 C 0 416666 A 4616666 D Common Stock 2020-04-28 4 C 0 151515 A 4768181 D Series A Preferred Stock 2020-04-28 4 C 0 3500000 0.00 D Common Stock 3500000 0 D Series B Preferred Stock 2020-04-28 4 C 0 625000 0.00 D Common Stock 625000 0 D Series C Preferred Stock 2020-04-28 4 C 0 416666 0.00 D Common Stock 416666 0 D Series D Preferred Stock 2020-04-28 4 C 0 151515 0.00 D Common Stock 151515 0 D Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares. /s/ Jennifer J. Carlson, Attorney-in-Fact 2020-04-28